FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulf Dahlström

Research Profile

Disorders

Geographic Areas

Sweden

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Questionnaires

Procedures

Co-author Network

Publications

TOP 3
Björn Agvall; Urban Alehagen; Ulf Dahlström
The benefits of using a heart failure management programme in Swedish primary healthcare.
Urban Alehagen; Ulf Dahlström; Jens F Rehfeld; Jens P Goetze
Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Peter Johansson; Barbara Riegel; Erland Svensson; Urban Alehagen; Anders Broström; Ulf Dahlström; Tiny Jaarsma
The contribution of heart failure to sleep disturbances and depressive symptoms in older adults.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulf Dahlström (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Björn Agvall; Urban Alehagen; Ulf Dahlström
The benefits of using a heart failure management programme in Swedish primary healthcare.
European journal of heart failure 2013;15(2):228-36.
2013: Urban Alehagen; Ulf Dahlström; Jens F Rehfeld; Jens P Goetze
Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Journal of cardiac failure 2013;19(1):31-9.
2012: Peter Johansson; Barbara Riegel; Erland Svensson; Urban Alehagen; Anders Broström; Ulf Dahlström; Tiny Jaarsma
The contribution of heart failure to sleep disturbances and depressive symptoms in older adults.
Journal of geriatric psychiatry and neurology 2012;25(3):179-87.
2012: Peter Johansson; Eva Svanborg; Urban Alehagen; Ulf Dahlström; Anders Broström
Clinical characteristics and mortality risk in relation to obstructive and central sleep apnoea in community-dwelling elderly individuals: a 7-year follow-up.
Age and ageing 2012;41(4):468-74.
2011: Simona I Chisalita; Ulf Dahlström; Hans J Arnqvist; Urban Alehagen
Increased IGF1 levels in relation to heart failure and cardiovascular mortality in an elderly population: impact of ACE inhibitors.
European journal of endocrinology / European Federation of Endocrine Societies 2011;165(6):891-8.
2011: Peter Johansson; Eva Svanborg; Martin Ulander; Urban Alehagen; Ulf Dahlström; Anders Broström
Sleep disordered breathing in community dwelling elderly: associations with cardiovascular disease, impaired systolic function, and mortality after a six-year follow-up.
Sleep medicine 2011;12(8):748-53.
2011: Liza Ljungberg; Urban Alehagen; Hanna Björck; Ulf Dahlström; Rachel De Basso; Toste Länne; Karin Persson
The association between circulating angiotensin-converting enzyme and cardiovascular risk in the elderly: a cross-sectional study.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2011;12(3):281-9.
2011: Hanna M Björck; Ulf Dahlström; Rachel De Basso; Per Eriksson; Liza U Ljungberg; Karin Persson; Urban Alehagen; Toste Länne
Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure.
American journal of hypertension 2011;24(7):802-8.
2011: Urban Alehagen; Ulf Dahlström; Jens F Rehfeld; Jens P Goetze
Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
JAMA : the journal of the American Medical Association 2011;305(20):2088-95.
2010: Urban Alehagen; Ulf Dahlström; Jens F Rehfeld; Jens P Goetze
Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
Clinical chemistry 2010;56(11):1718-24.
2010: Ulf Dahlström; Gerasimos Filippatos; Aldo Maggioni; Luigi Tavazzi; Faiez Zannad
Heart Failure Pilot protocol.
European heart journal 2010;31(18):2184-6.
2010: Peter Johansson; Urban Alehagen; Erland Svensson; Eva Svanborg; Ulf Dahlström; Anders Broström
Determinants of global perceived health in community-dwelling elderly screened for heart failure and sleep-disordered breathing.
The Journal of cardiovascular nursing 2010;25(5):E16-26.
2010: Peter Johansson; Kristoffer Arestedt; Urban Alehagen; Eva Svanborg; Ulf Dahlström; Anders Broström
Sleep disordered breathing, insomnia, and health related quality of life -- a comparison between age and gender matched elderly with heart failure or without cardiovascular disease.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2010;9(2):108-17.
2010: Urban Alehagen; Ulf Dahlström; Tomas L Lindahl
Low plasma concentrations of coagulation factors II, VII and XI indicate increased risk among elderly with symptoms of heart failure.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(1):62-9.
2010: Asa Jonsson; Magnus Edner; Urban Alehagen; Ulf Dahlström
Heart failure registry: a valuable tool for improving the management of patients with heart failure.
European journal of heart failure 2010;12(1):25-31.
2009: Ulf Dahlström
[Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
Läkartidningen 2009;106(42):2674-5.
2009: Peter Johansson; Urban Alehagen; Eva Svanborg; Ulf Dahlström; Anders Broström
Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness.
Sleep medicine 2009;10(9):1005-11.
2009: Urban Alehagen; Anne Ericsson; Ulf Dahlström
Are there any significant differences between females and males in the management of heart failure? Gender aspects of an elderly population with symptoms associated with heart failure.
Journal of cardiac failure 2009;15(6):501-7.
2009: Urban Alehagen; Ulf Dahlström
Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure.
International journal of cardiology 2009;133(2):233-40.
2009: Urban Alehagen; Ulf Dahlström; Tomas L Lindahl
Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care.
European journal of heart failure 2009;11(4):354-60.
2009: H M Björck; Toste Länne; Urban Alehagen; K Persson; L Rundkvist; A Hamsten; Ulf Dahlström; Per Eriksson
Association of genetic variation on chromosome 9p21.3 and arterial stiffness.
Journal of internal medicine 2009;265(3):373-81.
2008: Peter Johansson; Anders Broström; Ulf Dahlström; Urban Alehagen
Global perceived health and health-related quality of life in elderly primary care patients with symptoms of heart failure.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2008;7(4):269-76.
2008: Peter Johansson; Anders Broström; Ulf Dahlström; Urban Alehagen
Global perceived health and ten-year cardiovascular mortality in elderly primary care patients with possible heart failure.
European journal of heart failure 2008;10(10):1040-7.
2008: Ulf Dahlström; Ken McDonald; Alan Maisel
Integration of B-type natriuretic Peptide in heart failure outpatient programs.
Congestive heart failure (Greenwich, Conn.) 2008;14(4 Suppl 1):9-11.
2007: P Johansson; Ulf Dahlström; Urban Alehagen
Depressive symptoms and six-year cardiovascular mortality in elderly patients with and without heart failure.
Scandinavian cardiovascular journal : SCJ 2007;41(5):299-307.
2007: Ulf Dahlström; Kurt Boman; Lars-Ake Brodin; Inger Hagerman; Ronnie Willenheimer
[Treatment of heart failure and preserved systolic function].
Läkartidningen 2007;104(34):2348-50.
2007: Inger Hagerman; Lars-Ake Brodin; Ulf Dahlström; inger ekman; Ronnie Willenheimer; Kurt Boman
[Diastolic heart failure--symptoms and etiology].
Läkartidningen 2007;104(34):2345-7.
2007: Lars-Ake Brodin; Kurt Boman; Ulf Dahlström; Inger Hagerman; Ronnie Willenheimer
[Echocardiography refines the diagnosis in heart failure].
Läkartidningen 2007;104(34):2338-44.
2007: Ronnie Willenheimer; Lars-Ake Brodin; Kurt Boman; Inger Hagerman; Ulf Dahlström
[Definition of diastolic heart failure].
Läkartidningen 2007;104(34):2333-7.
2007: Ulf Dahlström
[Diastolic heart failure. Same symptoms but different definitions].
Läkartidningen 2007;104(34):2331.
2007: Urban Alehagen; Erland Svensson; Ulf Dahlström
Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.
Journal of cardiac failure 2007;13(6):452-61.
2007: Urban Alehagen; Jens Peter Goetze; Ulf Dahlström
Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
Clinica chimica acta; international journal of clinical chemistry 2007;382(1-2):8-14.
2006: Anna Strömberg; Ulf Dahlström; Bengt Fridlund
Computer-based education for patients with chronic heart failure. A randomised, controlled, multicentre trial of the effects on knowledge, compliance and quality of life.
Patient education and counseling 2006;64(1-3):128-35.
2006: Christer Ahlstrom; Peter Hult; Peter Rask; Jan-Erik Karlsson; Eva Nylander; Ulf Dahlström; Per Ask
Feature extraction for systolic heart murmur classification.
Annals of biomedical engineering 2006;34(11):1666-77.
2006: Ulf Dahlström; Urban Alehagen
[Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
Läkartidningen 2006;103(12):927-9.
2006: Peter Johansson; Ulf Dahlström; Anders Broström
Factors and interventions influencing health-related quality of life in patients with heart failure: a review of the literature.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2006;5(1):5-15.
2006: Peter Johansson; Ulf Dahlström; Anders Broström
Consequences and predictors of depression in patients with chronic heart failure: implications for nursing care and future research.
Progress in cardiovascular nursing 2006;21(4):202-11.
2006: Peter Johansson; Ulf Dahlström; Anders Broström
The measurement and prevalence of depression in patients with chronic heart failure.
Progress in cardiovascular nursing 2006;21(1):28-36.
2005: Björn Agvall; Lars Borgquist; Mats Foldevi; Ulf Dahlström
Cost of heart failure in Swedish primary healthcare.
Scandinavian journal of primary health care 2005;23(4):227-32.
2005: Anders Broström; Laila Hubbert; Per Jakobsson; Peter Johansson; Bengt Fridlund; Ulf Dahlström
Effects of long-term nocturnal oxygen treatment in patients with severe heart failure.
The Journal of cardiovascular nursing 2005;20(6):385-96.
2005: Urban Alehagen; Göran Lindstedt; L-A Levin; Ulf Dahlström
Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population.
International journal of cardiology 2005;100(1):125-33.
2005: Urban Alehagen; Göran Lindstedt; L-A Levin; Ulf Dahlström
The risk of cardiovascular death in elderly patients with possible heart failure. Results from a 6-year follow-up of a Swedish primary care population.
International journal of cardiology 2005;100(1):17-27.
2005: Jan Mårtensson; Anna Strömberg; Ulf Dahlström; Jan-Erik Karlsson; Bengt Fridlund
Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression.
European journal of heart failure 2005;7(3):393-403.
2005: Ulf Dahlström
Frequent non-cardiac comorbidities in patients with chronic heart failure.
European journal of heart failure 2005;7(3):309-16.
2005: Peter Hult; TT Fjällbrant; K Hildén; Ulf Dahlström; Bengt Wranne; Per Ask
Detection of the third heart sound using a tailored wavelet approach: method verification.
Medical & biological engineering & computing 2005;43(2):212-7.
2004: Urban Alehagen; Ulf Dahlström; Tomas L Lindahl
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure.
Thrombosis and haemostasis 2004;92(6):1250-8.
2004: Andreas Jekell; Akter Hossain; Urban Alehagen; Ulf Dahlström; Anders Rosén
Elevated circulating levels of thioredoxin and stress in chronic heart failure.
European journal of heart failure 2004;6(7):883-90.
2004: Anna Strömberg; Ulf Dahlström
Heart failure clinics have decreased mortality and hospitalisation rates in Sweden.
European heart journal 2004;25(15):1368-9; author reply 1368.
2004: Anders Broström; Anna Strömberg; Ulf Dahlström; Bengt Fridlund
Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure.
The Journal of cardiovascular nursing 2004;19(4):234-42.
2004: A Bergström; B Andersson; Magnus Edner; Eva Nylander; Hans Persson; Ulf Dahlström
Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
European journal of heart failure 2004;6(4):453-61.
2004: Peter Johansson; Mattias Agnebrink; Ulf Dahlström; Anders Broström
Measurement of health-related quality of life in chronic heart failure, from a nursing perspective-a review of the literature.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2004;3(1):7-20.
2004: Ulf Dahlström
Can natriuretic peptides be used for the diagnosis of diastolic heart failure?
European journal of heart failure 2004;6(3):281-7.
2004: Ulf Dahlström
[New treatment of heart failure. Angiotensin II receptor blockaders show promising results in an extensive study].
Läkartidningen 2004;101(9):742-3.
2004: Göran Lindstedt; Urban Alehagen; Ulf Dahlström
[Usefulness of BNP in heart failure. Shortages of a current review reflect th complexity of the problem].
Läkartidningen 2004;101(8):688-9.
2003: Urban Alehagen; Göran Lindstedt; Henry Eriksson; Ulf Dahlström
Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care.
Clinical chemistry 2003;49(8):1337-46.
2003: Anna Strömberg; Jan Mårtensson; Bengt Fridlund; L-A Levin; Jan-Erik Karlsson; Ulf Dahlström
Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial.
European heart journal 2003;24(11):1014-23.
2003: Anders Broström; Anna Strömberg; Ulf Dahlström; Bengt Fridlund
Congestive heart failure, spouses' support and the couple's sleep situation: a critical incident technique analysis.
Journal of clinical nursing 2003;12(2):223-33, 34.
2002: Anna Strömberg; Henrik Ahlén; Bengt Fridlund; Ulf Dahlström
Interactive education on CD-ROM-a new tool in the education of heart failure patients.
Patient education and counseling 2002;46(1):75-81.
2001: Göran Lindstedt; Ulf Dahlström; Per Fernlund; Maria Schaufelberger; Mats Stridsberg
[Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
Läkartidningen 2001;98(41):4444-8, 4450-2.
2001: Anders Broström; Anna Strömberg; Ulf Dahlström; Bengt Fridlund
Patients with congestive heart failure and their conceptions of their sleep situation.
Journal of advanced nursing 2001;34(4):520-9.
2001: Ulf Dahlström
Heart failure clinics: organization, development, and experiences.
Current opinion in cardiology 2001;16(3):174-9.
2001: B Agvall; Ulf Dahlström
Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences.
Scandinavian journal of primary health care 2001;19(1):14-9.
2001: Anna Strömberg; Jan Mårtensson; Bengt Fridlund; Ulf Dahlström
Nurse-led heart failure clinics in Sweden.
European journal of heart failure 2001;3(1):139-44.
2000: Bengt Peterzén; Hans Granfeldt; Urban Lönn; B Carnstam; Eva Nylander; Ulf Dahlström; Hans Rutberg; Henrik Casimir-Ahn
Management of patients with end-stage heart disease treated with an implantable left ventricular assist device in a nontransplanting center.
Journal of cardiothoracic and vascular anesthesia 2000;14(4):438-43.
2000: K Jansson; Ulf Dahlström; KE Karlberg; E Karlsson; O Nyquist; Eva Nylander
The value of repeated echocardiographic evaluation in patients with idiopathic dilated cardiomyopathy during treatment with metoprolol or captopril.
Scandinavian cardiovascular journal : SCJ 2000;34(3):293-300.
1999: Anna Strömberg; Anders Broström; Ulf Dahlström; Bengt Fridlund
Factors influencing patient compliance with therapeutic regimens in chronic heart failure: A critical incident technique analysis.
Heart & lung : the journal of critical care 1999;28(5):334-41.
1999: K Jansson; Inger Hagerman; R Ostlund; KE Karlberg; Eva Nylander; O Nyquist; Ulf Dahlström
The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy.
Clinical cardiology 1999;22(6):397-402.
1999: K Jansson; Ulf Dahlström; B E Karlberg; E Karlsson; Eva Nylander; O Nyquist; KE Karlberg
The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
Journal of internal medicine 1999;245(5):435-43.
1998: O Kongstad-Rasmussen; P Blomstrand; M Broqvist; Ulf Dahlström; Bengt Wranne
Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarction.
Clinical cardiology 1998;21(11):807-11.
1997: K Jansson; KE Karlberg; Eva Nylander; E Karlsson; O Nyquist; Ulf Dahlström
More favourable haemodynamic effects from metoprolol than from captopril in patients with dilated cardiomyopathy.
European heart journal 1997;18(7):1115-21.
1996: P Blomstrand; O Kongstad; M Broqvist; Ulf Dahlström; Bengt Wranne
Assessment of left ventricular diastolic function from mitral annulus motion, a comparison with pulsed Doppler measurements in patients with heart failure.
Clinical physiology (Oxford, England) 1996;16(5):483-93.
1995: K Jansson; Henrik Casimir-Ahn; Urban Lönn; Eva Nylander; Bengt Peterzén; Ulf Dahlström
[A heart-assist device. A life-saving mechanical circulatory support to be used while waiting for heart transplantation].
Läkartidningen 1995;92(38):3437-8, 3443-4.
1995: Hans Granfeldt; JO Solem; Urban Lönn; Bengt Peterzén; B Carnstam; Ulf Dahlström; K Jansson; Bansi Koul; Stig Steen; M Toom
The Linköping-Lund surgical experience with the HeartMate left ventricular assist system.
The Annals of thoracic surgery 1995;59(2 Suppl):S52-5.
1994: M Broqvist; H Arnqvist; Ulf Dahlström; J Larsson; Eva Nylander; J Permert
Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure--effects of long-term dietary supplementation.
European heart journal 1994;15(12):1641-50.
1994: L Andersson; K Gustavsson; Ulf Dahlström
[ACE inhibitors in heart failure. Increased safety in a cardiology clinic].
Läkartidningen 1994;91(36):3153-6.
1993: Ulf Dahlström; E Karlsson
Captopril and spironolactone therapy for refractory congestive heart failure.
The American journal of cardiology 1993;71(3):29A-33A.
1992: M Broqvist; Ulf Dahlström; E Karlsson; J Larsson
Muscle energy metabolism in severe chronic congestive heart failure--effect of treatment with enalapril.
European heart journal 1992;13(9):1217-24.
1992: M Broqvist; Ulf Dahlström; E Karlsson; J Larsson
Muscle water and electrolytes in severe chronic congestive heart failure before and after treatment with enalapril.
European heart journal 1992;13(2):243-50.
1990: K Jansson; Ulf Dahlström; E Karlsson; Eva Nylander; H Walfridsson; C Sonnhag
The value of exercise test, Holter monitoring, and programmed electrical stimulation in detection of ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
Pacing and clinical electrophysiology : PACE 1990;13(10):1261-7.
1989: M Broqvist; Ulf Dahlström; BE Karlberg; E Karlsson; T Marklund
Neuroendocrine response in acute heart failure and the influence of treatment.
European heart journal 1989;10(12):1075-83.
1989: J Ahlner; Rolf G G Andersson; Ulf Dahlström; Eva Nylander
Influence of long-term prenalterol treatment on the heart rate and the beta-adrenoceptor binding-sites in rat myocardium.
Pharmacology & toxicology 1989;64(1):43-6.
1988: J Ahlner; Rolf G G Andersson; K L Axelsson; Björn Bergdahl; Ulf Dahlström; Eva Swahn
Decreased plasma levels of cyclic GMP in patients with chest pain and angiographically normal coronary arteries.
Klinische Wochenschrift 1988;66(11):494-7.
1988: J Ahlner; Björn Bergdahl; Ulf Dahlström; J Ohlsson
Once daily dosing of enalapril in congestive heart failure.
Acta medica Scandinavica 1988;223(4):313-20.
1986: J Ahlner; Rolf G G Andersson; K L Axelsson; Ulf Dahlström; E L Rydell
Development of tolerance to glyceryl trinitrate in an isolated human peripheral vein and its relation to cyclic GMP metabolism.
Acta pharmacologica et toxicologica 1986;59(2):123-8.
1986: J Ahlner; Rolf G G Andersson; K L Axelsson; Björn Bergdahl; Ulf Dahlström; E L Rydell
The relaxant effect of glyceryltrinitrate on isolated human peripheral vein and its relation to cyclic GMP metabolism.
Acta pharmacologica et toxicologica 1986;58(2):129-36.
1984: Eva Nylander; Ulf Dahlström
Influence of long-term beta receptor stimulation with prenalterol on intrinsic heart rate in rats.
European journal of applied physiology and occupational physiology 1984;53(1):48-52.
1983: Ulf Dahlström; J Ahlner
[Drug therapy in heart failure. There is no ideal inotropic drug. Digitalis continues to defend its place].
Läkartidningen 1983;80(20):2135-6.